Helen Healy graduated with an M.B.B.S. degree from the University of Adelaide in 1978, as a Fellow of the Royal Australasian College of Physicians in 1984, and with a Ph.D. degree from Sydney University in 1995. She is Head of Conjoint Kidney Research Laboratory and Director of Renal Services, Metro North, which has a population of around 1 million people and encompasses one of Australia’s largest tertiary teaching hospitals, the Royal Brisbane and Women’s Hospital. She is driving innovative service delivery models, reconfiguring chronic kidney disease (CKD) services to a community-based, high flow, light medical touch model. She is a Thought Leader in the Disease Prevention Program of Metro North’s CEO and is testing opportunistic identification of chronic disease in Emergency Department attendees with a reported eGFR<60 mls/min who are discharged. She is a Founding and Executive Member of CKD.QLD and Member of eKIDNAA, Australia wide collaboratives studying the natural history of CKD. She sits on the integrated eMR Business Reference Group, the clinical advisory body to Queensland Health for the statewide electronic health care record. Her Ph.D. degree studied the role of immunocompetent cells in animal models of glomerulonephritis. In 2005, she reorientated the program of the Conjoint Kidney Research Laboratory, at the Bancroft Centre, Queensland Institute of Medical Research, to dissecting the mechanisms of CKD in humans. Her group has published 9 papers in the area, including the first description of how human specialized kidney cells regulate the local inflammatory network, which was cited among the top 25% abstracts at the World Congress of Nephrology 2009.
Biography Updated on 5 July 2011